# Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

> **NCT02334488** · PHASE3 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 329 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate sodium

## Key facts

- **NCT ID:** NCT02334488
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-11
- **Primary completion:** 2019-05-31
- **Final completion:** 2020-07-03
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2021-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02334488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02334488, "Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02334488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*